Most favoured nation is a contractual term. It effectively means you get the lowest price of all buyers. It’s the name trump also gives to his policy’s.
It doesn’t mean there is a most favoured nation clause in the contract, there may be, but there may not be. It is something most try to avoid due to complexity to administer and limitations it poses.
An example being a country like Mexico, or another country with a lower national income, it could mean you can’t access that market as you need to keep your price above the USA. You also have forex impacts, meaning if something happens to the US dollar, other countries could drop below their pricing, meaning you need to constantly monitor forex across the world and move USA pricing accordingly or you breach contract.
i doubt there is a most favoured nation clause, and trump just uses this term to say he wants the best pricing in the world.
both novo and el Lilly have done a deal, and in return they avoid tariffs for 3 years, so it covers all drugs now on the market, from ozempic, to mounjaro, and a price agreed for the pill form. The deal seems mutually beneficial. They get wide access to the market, and Americans get better pricing, it won’t be the crazy 1000 dollar a pen stuff we see, but it’s still very expensive at over 300 usd for the higher doses.
So the price is lower, but still comparable to other countries, and much of it is hidden in the USA insurance system, as now both Medicare and Mediaid will ne able to provide, meaning much wider access for Americans, thus enabling the obesity issue to be more widely addressed and the health conditions obesity causes, alleviated.
there is also a deal done on the tablet form of el Lilly’s drug, and it seems to be lower cost than the pens, likely as it is not as effective but also enables el Lilly to barter it for wide access to maintain the higher price point of the pens.
none of it means any other countries prices will drop. Our goverment don’t appear to give a shit and have done a deal for the nhs whilst agreeing an increase for private prescriptions, but also limiting it on the nhs. Where I think it will remain limited until generic versions of wegovy hit the market.